Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
‘Part of something bigger than myself’: Clinicians explain why they chose ID
When we started our “Hooked on ID” series 6 years ago, the pitch was simple: “The field of ID has never been more important. Tell us why you chose it.”
Screening, outbreak containment crucial for infection prevention
Although Candida auris and Clostridioides difficile continue to be dangerous for patients, research published throughout this year has highlighted strides made in outbreak prevention and understanding nosocomial infections.
PharmDs dig into the literature to explore the latest in ID care
Each month, we ask one of our PharmD columnists to dig into the literature to find evidence-based answers to important clinical questions in the field of infectious diseases.
Log in or Sign up for Free to view tailored content for your specialty!
The year in ID: New vaccines, workforce shortages, AI and more
Each cover of Healio | Infectious Disease News is topped by a feature story on an emerging topic in the field of ID.
New medical conference will focus on antimicrobial resistance
A new annual medical conference will focus on the topic of antimicrobial resistance, organizers announced Friday.
2024 ID fellowship match reverses post-pandemic declines, officials say
The number of physicians who matched in adult and pediatric infectious diseases this year improved slightly over 2023, signaling a potential boost to the specialties, officials said.
Hooked on ID with Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP
I initially became hooked on ID when I was a medical student rounding on ID service and was evaluating a person with pneumonia who had just expectorated purulent sputum.
VIDEO: ‘Long way to go’ in HCV treatment, elimination
PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine and director of hepatology at Stanford University, discusses recent efforts to advance elimination of hepatitis C virus.
Hooked on ID with Vani Vannappagari, MBBS, PhD, MPH
As a physician trained in India, I saw the devastating impact of infectious diseases like TB, malaria and waterborne illnesses, and the profound difference public health interventions can have. That led to my career in global health.
Q&A: How to improve HCV care among women who use opioids
Less than 10% of reproductive aged women with opioid use disorder and hepatitis C virus are treated for HCV, according to findings published in Clinical Infectious Diseases.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read